Meeting the Demand for Unrelated Donors in the Midst of the COVID-19 Pandemic: Rapid Adaptations by the National Marrow Donor Program and Its Network Partners Ensured a Safe Supply of Donor Products
暂无分享,去创建一个
S. Devine | Gretta L. Stritesky | J. Auletta | J. Novakovich | J. Newman | Sade T. Fridy-Chesser | Karl Hailperin
[1] D. Curtis,et al. Variable CD34+ recovery of cryopreserved allogeneic HPC products: transplant implications during the COVID-19 pandemic , 2020, Blood advances.
[2] W. Wood,et al. Real-World Issues and Potential Solutions in Hematopoietic Cell Transplantation during the COVID-19 Pandemic: Perspectives from the Worldwide Network for Blood and Marrow Transplantation and Center for International Blood and Marrow Transplant Research Health Services and International Studies Commi , 2020, Biology of Blood and Marrow Transplantation.
[3] W. Wood,et al. Real-world issues and potential solutions in HCT during the COVID-19 pandemic: Perspectives from the WBMT and the CIBMTR's Health Services and International Studies Committee , 2020, Biology of Blood and Marrow Transplantation.
[4] B. Grenfell,et al. Disease and healthcare burden of COVID-19 in the United States , 2020, Nature Medicine.
[5] S. Galea,et al. COVID-19 Pandemic, Unemployment, and Civil Unrest: Underlying Deep Racial and Socioeconomic Divides. , 2020, JAMA.
[6] S. Montoto,et al. Correction: The challenge of COVID-19 and hematopoietic cell transplantation: EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy , 2020, Bone Marrow Transplantation.
[7] S. Montoto,et al. The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy. , 2020, Bone marrow transplantation.
[8] Kyle M. Hebert,et al. Hematopoietic Cell Transplantation with Cryopreserved Grafts for Severe Aplastic Anemia , 2020, Biology of Blood and Marrow Transplantation.
[9] David M. Hartley,et al. Addressing the Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Hematopoietic Cell Transplantation: Learning Networks as a Means for Sharing Best Practices , 2020, Biology of Blood and Marrow Transplantation.
[10] A. Artz,et al. Securing the graft during pandemic: are we ready for cryopreservation for all? , 2020, Biology of Blood and Marrow Transplantation.
[11] M. Horowitz,et al. Graft Cryopreservation Does Not Impact Overall Survival after Allogeneic Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis , 2020, Biology of Blood and Marrow Transplantation.
[12] J. Szer,et al. The impact of COVID-19 on the provision of donor hematopoietic stem cell products worldwide: collateral damage , 2020, Bone Marrow Transplantation.
[13] Donald Trump,et al. Proclamation on Declaring a National Emergency Concerning the Novel Coronavirus Disease (COVID-19) Outbreak , 2020 .
[14] Michael Bell,et al. Initial Public Health Response and Interim Clinical Guidance for the 2019 Novel Coronavirus Outbreak — United States, December 31, 2019–February 4, 2020 , 2020, MMWR. Morbidity and mortality weekly report.
[15] P. Hari,et al. Current Use and Trends in Hematopoietic Cell Transplantation in the United States. , 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[16] J. Wagner,et al. Rapid transport and infusion of hematopoietic cells is associated with improved outcome after myeloablative therapy and unrelated donor transplant. , 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[17] M. Minden,et al. Similar outcomes of cryopreserved allogeneic peripheral stem cell transplants (PBSCT) compared to fresh allografts. , 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[18] A. Zander,et al. Long‐term follow‐up of leukaemia patients after related cryopreserved allogeneic bone marrow transplantation , 1997, British journal of haematology.
[19] Mandalay Grems,et al. Standards , 1987, CACM.